With chemotherapy currently the main form of treatment, HG-CT-1 is based on a potentially more benign and effective CAR-T therapy, which uses and modifies a patient's own immune cells to recognize and ...
Recruitment of patients for the trials has begun. This Phase I trial is designed as a dose-escalation study to evaluate the safety profile of HG-CT-1 in adult patients with R/R AML. Key secondary ...
INR:6263. 23 tarikh ka lottery TaiGen Biopharma's new anti-influenza drug is approved for clinical trials in the U.S., without the restriction of taking the ...
INR:7155. singam lottery apps K drug/chemotherapy combination failed in phase III clinical trial of bladder cancer Transcenta's TST001 completed first patient ...